Ascletis Pharma-B (01672.HK) Announces Positive Preclinical Data from Its Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity

Zhitong Finance APP news, Ascletis Pharma-B (01672.HK) announced that its industry-leading once-weekly oral peptide pipeline has obtained positive preclinical data, demonstrating a long half-life and superior bioavailability.